Our study showed topical tacrolimus could reverse high-dose UVB irradiation-induced epidermal LC reduction by inhibiting TNF-α secretion in keratinocytes via regulation of NF-κB/p65. The gene discussed is NFKB1; the disease is laryngotracheoesophageal cleft.